1. Obesity contributes to up to half of new diabetes cases annually in the United States;Journal of the American Heart Association Report,2021
2. Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence;J Cardiovasc Pharmacol Ther,2022